Update on Phase 3 Librexia ACS Trial

Go back to Update on Phase 3 Librexia ACS Trial
Bristol-Myers Squibb (NYSE: BMY) Delayed: 60.56 -0.01 (0.02%)
Previous Close $60.57    52 Week High $77.12 
Open $61.00    52 Week Low $49.03 
Day High $61.56    P/E 39.32 
Day Low $60.00    EPS $1.54 
Volume 6,134,745